{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:06Z","timestamp":1740106926726,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00277-022-05048-7","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T09:02:53Z","timestamp":1674032573000},"page":"487-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vinblastine as a bridge to 7\u2009+\u20093 in acute myeloid leukaemia"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-487X","authenticated-orcid":false,"given":"Fernando","family":"De la Garza-Salazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-9345","authenticated-orcid":false,"given":"Andr\u00e9s","family":"G\u00f3mez-De Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-439X","authenticated-orcid":false,"given":"Perla R.","family":"Colunga-Pedraza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"issue":"3","key":"5048_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/bjh.13146","volume":"168","author":"K Kuo","year":"2015","unstructured":"Kuo K, Callum J, Panzarella T, Jacks L, Brandwein J, Crump M et al (2015) A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. Br J Haematol 168(3):384\u2013394. https:\/\/doi.org\/10.1111\/bjh.13146","journal-title":"Br J Haematol"},{"issue":"10297","key":"5048_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0140-6736(21)01656-1","volume":"398","author":"D Agren","year":"2021","unstructured":"Agren D (2021) Lack of medicines in Mexico. Lancet 398(10297):289\u2013290. https:\/\/doi.org\/10.1016\/S0140-6736(21)01656-1","journal-title":"Lancet"},{"issue":"4","key":"5048_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.4161\/cbt.12.4.16909","volume":"12","author":"D Bates","year":"2011","unstructured":"Bates D, Salerni B, Lowrey C, Eastman A (2011) Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis. Cancer Biol Ther 12(4):314\u201325. https:\/\/doi.org\/10.4161\/cbt.12.4.16909","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"5048_CR4","first-page":"11","volume":"13","author":"R Mart\u00ednez","year":"2012","unstructured":"Mart\u00ednez R, Ceballos A, Flores J, Sierra J, G\u00f3mez D (2012) \u00bfEs la vinblastina \u00fatil en la leucemia aguda mielobl\u00e1stica? Revista de Hematolog\u00eda 13(1):11\u201315","journal-title":"Revista de Hematolog\u00eda"},{"issue":"6","key":"5048_CR5","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/j.clml.2019.12.015","volume":"20","author":"R Demichelis","year":"2020","unstructured":"Demichelis R, Zapata N, Leyto F, Terreros E, Carrillo A, Monta\u00f1o E et al (2020) Acute myeloid leukemia in Mexico: the specific challenges of a developing country. Results From a Multicenter National Registry. Clin Lymphoma Myeloma Leuk 20(6):e295\u2013e303. https:\/\/doi.org\/10.1016\/j.clml.2019.12.015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5048_CR6","unstructured":"Tan D, Hwang W, Goh YT. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore [Internet]. PubMed. 2022 [cited 11 July 2022]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15902342\/"},{"issue":"10","key":"5048_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/j.1537-2995.2007.01406.x","volume":"47","author":"G Bug","year":"2007","unstructured":"Bug G, Anargyrou K, Tonn T, Bialleck H, Seifried E, Hoelzer D et al (2007) Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 47(10):1843\u201350. https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01406.x","journal-title":"Transfusion"},{"issue":"9","key":"5048_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s002770000162","volume":"79","author":"A Thi\u00e9baut","year":"2000","unstructured":"Thi\u00e9baut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E (2000) Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 79(9):501\u20136. https:\/\/doi.org\/10.1007\/s002770000162","journal-title":"Ann Hematol"},{"issue":"10","key":"5048_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3109\/10428194.2016.1142083","volume":"57","author":"A Mamez","year":"2016","unstructured":"Mamez A, Raffoux E, Chevret S, Lemiale V, Boissel N, Canet E et al (2016) Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leuk Lymphoma 57(10):2281\u201388. https:\/\/doi.org\/10.3109\/10428194.2016.1142083","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5048_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clml.2018.02.002","volume":"18","author":"J Jaime-P\u00e9rez","year":"2018","unstructured":"Jaime-P\u00e9rez J, Padilla-Medina J, Fern\u00e1ndez L, Herrera-Garza J, Guti\u00e9rrez-Aguirre C, Tar\u00edn-Arzaga L et al (2018) Outcomes of adolescents and young adults with acute myeloid leukemia treated in a single Latin American center. Clin Lymphoma Myeloma Leuk 18(4):286\u201392. https:\/\/doi.org\/10.1016\/j.clml.2018.02.002","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-05048-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-05048-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-05048-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T09:11:43Z","timestamp":1675156303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-05048-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["5048"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-05048-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by our local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}